跳至主要内容
临床试验/EUCTR2020-001960-28-ES
EUCTR2020-001960-28-ES进行中(未招募)1 期

Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19)

Investigation Institute Bioaraba0 个研究点目标入组 108 人开始时间: 2020年5月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Older patients of both sexes
  • - Admitted to the Respiratory and / or Internal Medicine Unit of the Hospital De Santiago, the OSI Araba HUA is walking due to pneumonia
  • - Possibility for observation during the treatment period
  • - Signature of written and, exceptionally oral, informed consent
  • - Have requested the test for SARS-CoV-2 (nasopharyngeal exudate PCR) and obtain positive results
  • - Having a deficiency of vitamin D (25 (OH) vitamin D), defined by blood levels below 30 mg / ml
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 70
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 48

排除标准

  • - Patients taking any type of vitamin D supplement
  • - Patients with hypoparathyroidism
  • - Pregnant or lactating women
  • - Patients in whom vitamin D administration is formally contraindicated
  • - Patients who cannot take vitamin D orally at the time of enrollment

研究者

发起方
Investigation Institute Bioaraba

相似试验